Browse our news

Researchers at Nottingham Trent University are involved in a study to develop a new type of treatment for inflammatory bowel disease (IBD), a condition affecting over five million people worldwide.

ntu.ac.uk/about-us/news/news-articles/2025/05/pioneering-rna-nanotherapy-offers-hope-for-inflammatory-bowel-disease-patients

Vitamin B12 deficiency in pregnancy can disrupt how fat is processed in the body, potentially raising the risk of diabetes and heart problems for both mother and offspring, a new study suggests.

ntu.ac.uk/about-us/news/news-articles/2025/05/vitamin-b12-deficiency-in-pregnancy-could-pose-metabolic-health-risk,-research-suggests

Carnosine, a rapidly-degrading compound which may play a role in controlling blood sugar levels could be kept in the body for longer by inhibiting the enzymes that break it down, a new study suggests.

ntu.ac.uk/about-us/news/news-articles/2025/05/lifespan-of-glucose-controlling-molecule-could-be-extended,-helping-protect-against-obesity,-research-suggests

Scientists have developed copper oxide nanoparticles which can be coated onto implanted medical devices to reduce the risk of infection after operations.

ntu.ac.uk/about-us/news/news-articles/2025/02/implanted-medical-devices-coated-with-copper-nanoparticles-could-reduce-infection-risk,-study-suggests

Nottinghamshire Festival of Science and Curiosity (FOSAC) is back, bringing a week of free, hands-on science activities for young people and families this February half-term.

ntu.ac.uk/about-us/news/news-articles/2025/01/nottinghamshire-festival-of-science-and-curiosity-marks-a-decade-of-discovery

Scientists have revealed that a toxin found in the blood of patients with chronic kidney disease (CKD) damages the body’s protective blood–brain barrier, likely contributing to the risk of stroke.

ntu.ac.uk/about-us/news/news-articles/2024/12/toxin-in-blood-of-kidney-disease-patients-could-contribute-to-stroke-risk,-study-suggests

A successful programme to train the next generation of Nottingham bioscientists from the city’s two universities has secured £14 million funding from UK Research and Innovation (UKRI).

ntu.ac.uk/about-us/news/news-articles/2024/11/successful-scientist-training-programme-receives-14m-boost

Scientists are investigating potential new treatments to tackle delayed and ongoing pain experienced by people who underwent chemotherapy for cancer when they were children.

ntu.ac.uk/about-us/news/news-articles/2024/10/study-seeks-to-tackle-pain-in-adult-survivors-of-childhood-cancer

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s Disease.

ntu.ac.uk/about-us/news/news-articles/2024/10/promising-first-in-alzheimers-drug-development

Researchers are embarking on a first of its kind study to utilise ultrasound and light therapies to investigate a non-invasive and targeted treatment of Alzheimer’s, dementia and Parkinson’s.

ntu.ac.uk/about-us/news/news-articles/2024/09/1-million-funding-from-the-eranda-rothschild-foundation-to-investigate-novel,-non-invasive-treatment-for-alzheimers,-dementia-and-parkinsons